Analysed ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) News Sources
Acadia Pharmaceuticals Announces DAYBUE® STIX (trofinetide) is Now Broadly Available in the United States for the Treatment of Rett Syndrome
07-04-2026
yahoo.com
A Look At ACADIA Pharmaceuticals (ACAD) Valuation As Shares Trade Near Recent Levels
05-04-2026
yahoo.com
Acadia Pharmaceuticals upgraded on improve risk-reward profile following pullback
25-03-2026
proactiveinvestors.com
ACADIA Pharmaceuticals Maps Key CNS Readouts: Remlifanserin ADP Data Due Aug–Oct, ACP-211 Next Year
17-03-2026
marketbeat.com
Assessing ACADIA Pharmaceuticals (ACAD) Valuation After Recent Share Price Weakness
16-03-2026
yahoo.com
What is the current price of ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ)?
The current price of ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) is $21.74.
ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) absolute price change since previous trading day?
The absolute price change of ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) since the previous trading day is $-0.83.
ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) percentage price change since previous trading day?
The percentage price change of ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) since the previous trading day is -3.6774%.
What is the most recent average sentiment score for ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ)?
The most recent average sentiment score for ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ)?
The most recent sentiment for ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) is .
SEC-8K** Filing Available For ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.